06Feb/13

Biogen Idec to Acquire Full Rights and Control of TYSABRI from Elan for … – Businessweek

February 6, 2013Monoclonal Anti-CD20 Antibodiesadmin

Biogen Idec to Acquire Full Rights and Control of TYSABRI from Elan for …
Businessweek
… including uncertainty inherent in regulatory review of the transaction, our dependence on our three principal products, AVONEX™ (interferon beta-1a), TYSABRI and RITUXAN™ (rituximab), the importance of TYSABRI’s sales growth, uncertainty of …
Biogen Idec to Acquire Full Rights and Control of TYSABRI(R) from Elan for …MarketWatch (press release)

all 74 news articles »

06Feb/13

2 antibodies are better than 1 – EurekAlert (press release)

February 6, 2013Antibodiesadmin

2 antibodies are better than 1EurekAlert (press release)Cancer drugs of the new, molecular generation destroy malignant breast tumors in a targeted manner: They block characteristic molecules on tumor cells – receptors for the hormones estrogen or prog…

06Feb/13

Biogen Idec to Acquire Full Rights and Control of TYSABRI® from Elan for … – The Herald | HeraldOnline.com

February 6, 2013Monoclonal Anti-CD20 Antibodiesadmin

Biogen Idec to Acquire Full Rights and Control of TYSABRI® from Elan for …
The Herald | HeraldOnline.com
… (interferon beta-1a), TYSABRI and RITUXAN® (rituximab), the importance of TYSABRI’s sales growth, uncertainty of success in commercializing and developing other products, product competition, the occurrence of adverse safety events with our …

and more »

06Feb/13

New Zealand takes significant step towards national hospital medicines list – The Pharma Letter

February 6, 2013Monoclonal Anti-CD20 Antibodiesadmin

New Zealand takes significant step towards national hospital medicines listThe Pharma LetterOne of the changes has been the addition of rituximab (MabThera, from Roche) to the rheumatology list. Rituximab, a targeted biologic medicine, had already been…

06Feb/13

High-dose Vorinostat effective at treating relapsed lymphomas – HealthCanal.com

February 6, 2013Monoclonal Anti-CD20 Antibodiesadmin

High-dose Vorinostat effective at treating relapsed lymphomasHealthCanal.comPreclinical studies at Fred Hutch and other research centers have found Vorinostat to be effective when used along with the standard chemotherapy combo, which is known by the a…

05Feb/13

Cells Predict Onset of Graft-Versus-Host Disease in Men Receiving Bone … – Science Daily (press release)

February 5, 2013Monoclonal Anti-CD20 Antibodiesadmin

Cells Predict Onset of Graft-Versus-Host Disease in Men Receiving Bone …Science Daily (press release)Miklos and his associates have shown in other studies that an injectable drug called rituximab (itself an antibody) that attacks B cells while sparin…

05Feb/13

No hay riesgos por Rituximab – Comunicado-Prensa.com (Comunicado de prensa)

February 5, 2013Monoclonal Anti-CD20 Antibodiesadmin

No hay riesgos por Rituximab
Comunicado-Prensa.com (Comunicado de prensa)
Hasta la fecha no hay ningún reporte confirmado del riesgo de efectos adversos graves de Rituximab ni muertes asociadas al tratamiento con este medicamento. Así lo confirma un comunicado del Laboratorio Roche, que comercializa Rituximab en …

04Feb/13

PHARMAC takes significant step towards national hospital medicines list – New Zealand Doctor Online

February 4, 2013Monoclonal Anti-CD20 Antibodiesadmin

PHARMAC takes significant step towards national hospital medicines listNew Zealand Doctor OnlineOne of the changes has been the addition of rituximab (Mabthera) to the rheumatology list. Rituximab, a targeted biologic medicine, had already been availab…

04Feb/13

Cells predict onset of graft-versus-host disease in men receiving BMTs from … – EurekAlert (press release)

February 4, 2013Monoclonal Anti-CD20 Antibodiesadmin

Cells predict onset of graft-versus-host disease in men receiving BMTs from …EurekAlert (press release)Miklos and his associates have shown in other studies that an injectable drug called rituximab (itself an antibody) that attacks B cells while spar…

04Feb/13

Precio Rituximab será regulado por Comisión en Colombia – Comunicado-Prensa.com (Comunicado de prensa)

February 4, 2013Monoclonal Anti-CD20 Antibodiesadmin

Precio Rituximab será regulado por Comisión en Colombia
Comunicado-Prensa.com (Comunicado de prensa)
La Comisión Nacional de Precios de Medicamentos y Dispositivos Médicos del Ministerio de Comercio, Industria y Turismo aprobó el ingreso de Rituximab y otros 80 medicamentos al régimen de control directo de precios. A través de la circular 001 del 30 …

Category Archives: Antibodies